117 related articles for article (PubMed ID: 27572461)
41. Activation of mouse and human peroxisome proliferator-activated receptor-alpha (PPARα) by perfluoroalkyl acids (PFAAs): further investigation of C4-C12 compounds.
Wolf CJ; Schmid JE; Lau C; Abbott BD
Reprod Toxicol; 2012 Jul; 33(4):546-551. PubMed ID: 22107727
[TBL] [Abstract][Full Text] [Related]
42. Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes.
Bjork JA; Butenhoff JL; Wallace KB
Toxicology; 2011 Oct; 288(1-3):8-17. PubMed ID: 21723365
[TBL] [Abstract][Full Text] [Related]
43. [Characteristics, use and toxicity of fluorochemicals: review of the literature].
Negri S; Maestri L; Esabon G; Ferrari M; Zadra P; Ghittori S; Imbriani M
G Ital Med Lav Ergon; 2008; 30(1):61-74. PubMed ID: 18700679
[TBL] [Abstract][Full Text] [Related]
44. Distributions of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in Japan and their toxicities.
Nakayama S; Harada K; Inoue K; Sasaki K; Seery B; Saito N; Koizumi A
Environ Sci; 2005; 12(6):293-313. PubMed ID: 16609670
[TBL] [Abstract][Full Text] [Related]
45. Does exposure to perfluoroalkyl acids present a risk to human health?
Rosen MB; Lau C; Corton JC
Toxicol Sci; 2009 Sep; 111(1):1-3. PubMed ID: 19561327
[No Abstract] [Full Text] [Related]
46. Pre- and post-diagnostic blood profiles of perfluoroalkyl acids in type 2 diabetes mellitus cases and controls.
Charles D; Berg V; Nøst TH; Huber S; Sandanger TM; Rylander C
Environ Int; 2020 Dec; 145():106095. PubMed ID: 32919259
[TBL] [Abstract][Full Text] [Related]
47. Perfluoroalkyl acids in children and their mothers: Association with drinking water and time trends of inner exposures--Results of the Duisburg birth cohort and Bochum cohort studies.
Wilhelm M; Wittsiepe J; Völkel W; Fromme H; Kasper-Sonnenberg M
Int J Hyg Environ Health; 2015 Oct; 218(7):645-55. PubMed ID: 26212496
[TBL] [Abstract][Full Text] [Related]
48. Impacts of two perfluorinated compounds (PFOS and PFOA) on human hepatoma cells: cytotoxicity but no genotoxicity?
Florentin A; Deblonde T; Diguio N; Hautemaniere A; Hartemann P
Int J Hyg Environ Health; 2011 Nov; 214(6):493-9. PubMed ID: 21676652
[TBL] [Abstract][Full Text] [Related]
49. Perfluorinated chemicals, PFOS and PFOA, enhance the estrogenic effects of 17β-estradiol in T47D human breast cancer cells.
Sonthithai P; Suriyo T; Thiantanawat A; Watcharasit P; Ruchirawat M; Satayavivad J
J Appl Toxicol; 2016 Jun; 36(6):790-801. PubMed ID: 26234195
[TBL] [Abstract][Full Text] [Related]
50. Combined effects of PFOS and PFOA on zebrafish (Danio rerio) embryos.
Ding G; Zhang J; Chen Y; Wang L; Wang M; Xiong D; Sun Y
Arch Environ Contam Toxicol; 2013 May; 64(4):668-75. PubMed ID: 23479250
[TBL] [Abstract][Full Text] [Related]
51. Toxicity of perfluorooctane sulfonate and perfluorooctanoic acid to plants and aquatic invertebrates.
Li MH
Environ Toxicol; 2009 Feb; 24(1):95-101. PubMed ID: 18461560
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of the binding of perfluorinated compound to pepsin: Spectroscopic analysis and molecular docking.
Yue Y; Sun Y; Yan X; Liu J; Zhao S; Zhang J
Chemosphere; 2016 Oct; 161():475-481. PubMed ID: 27459159
[TBL] [Abstract][Full Text] [Related]
53. Endocrine and developmental effects in Atlantic salmon (Salmo salar) exposed to perfluorooctane sulfonic or perfluorooctane carboxylic acids.
Spachmo B; Arukwe A
Aquat Toxicol; 2012 Feb; 108():112-24. PubMed ID: 22265611
[TBL] [Abstract][Full Text] [Related]
54. Exposure to perfluorinated compounds and human semen quality in Arctic and European populations.
Toft G; Jönsson BA; Lindh CH; Giwercman A; Spano M; Heederik D; Lenters V; Vermeulen R; Rylander L; Pedersen HS; Ludwicki JK; Zviezdai V; Bonde JP
Hum Reprod; 2012 Aug; 27(8):2532-40. PubMed ID: 22647447
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of estrogenic activities and mechanism of action of perfluorinated chemicals determined by vitellogenin induction in primary cultured tilapia hepatocytes.
Liu C; Du Y; Zhou B
Aquat Toxicol; 2007 Dec; 85(4):267-77. PubMed ID: 17980923
[TBL] [Abstract][Full Text] [Related]
56. Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants.
Okada E; Sasaki S; Saijo Y; Washino N; Miyashita C; Kobayashi S; Konishi K; Ito YM; Ito R; Nakata A; Iwasaki Y; Saito K; Nakazawa H; Kishi R
Environ Res; 2012 Jan; 112():118-25. PubMed ID: 22030285
[TBL] [Abstract][Full Text] [Related]
57. Ecological risk assessment of perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in marine environment using Isochrysis galbana, Paracentrotus lividus, Siriella armata and Psetta maxima.
Mhadhbi L; Rial D; Pérez S; Beiras R
J Environ Monit; 2012 May; 14(5):1375-82. PubMed ID: 22446617
[TBL] [Abstract][Full Text] [Related]
58. Nanofiltration and granular activated carbon treatment of perfluoroalkyl acids.
Appleman TD; Dickenson ER; Bellona C; Higgins CP
J Hazard Mater; 2013 Sep; 260():740-6. PubMed ID: 23846124
[TBL] [Abstract][Full Text] [Related]
59. Interaction of perfluoroalkyl acids with human liver fatty acid-binding protein.
Sheng N; Li J; Liu H; Zhang A; Dai J
Arch Toxicol; 2016 Jan; 90(1):217-27. PubMed ID: 25370009
[TBL] [Abstract][Full Text] [Related]
60. Dietary exposure to perfluorooctanoate or perfluorooctane sulfonate induces hypertrophy in centrilobular hepatocytes and alters the hepatic immune status in mice.
Qazi MR; Abedi MR; Nelson BD; DePierre JW; Abedi-Valugerdi M
Int Immunopharmacol; 2010 Nov; 10(11):1420-7. PubMed ID: 20816993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
